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ABSTRACT
Background: We evaluated changing HIV testing 
coverage and prevalence rates before and after 
expanding city-wide antiretroviral therapy (ART) 
programs in Lusaka, Zambia.
Methods: We conducted serial cross-sectional 
surveys on the University Teaching Hospital 
medical ward to assess HIV prevalence among 
inpatients of unknown status in 2003 and 2006. 
Willing participants received counseling and dual 
HIV rapid tests. We compared the proportion of 
inpatients receiving their test results in 2003 (off-
the-ward testing) to 2006 (on-the-ward).
Results: In 2003, none of 103 inpatients knew their 
HIV status or took ART; 99.0% (102/103) agreed to 
testing. In 2006, 49.3% (99 of 201) patients knew 
they were HIV-infected and were on ART; of those 
with unknown status, 98.0% (100/102) agreed to 
testing. In 2003, only 54.9% (56/102) received post-
test counseling and 98.2% (55/56) learned their 
status. In 2006, 99.0% (99/100) received post-test 
counseling and 99.1% (98 of 99) learned their status. 
In 2003, 62.8% (64 of 102) of status-unknown 
inpatients who agreed to testing were seropositive 
by dual rapid test, compared to 48.0% (48 of 100) of 
status-unknown inpatients in 2006. When including 
inpatients who already knew their seropositive 
status plus those unknowns who tested seropositive, 
the proportion of inpatients that was seropositive in 
2006 was 73.1% (147 of 201), higher than in 2003.
 
Conclusions: After ART program expansion, 
inpatients in 2006 were far more likely than their 
2003 counterparts to know their HIV status and to be 
taking ART. In both years, 63-73% of medical 
inpatients were HIV-infected and 98.5% of 
inpatients agreed to testing. On-the-ward testing in 
2006 avoided the 2003 problem of patient discharge 
before learning of their test results. Hospital-based 
HIV testing is an essential clinical service in high 
prevalence settings and can serve further as a 
surveillance system to help track the community 
impact of outpatient AIDS services in Africa.
The HIV epidemic in sub-Saharan Africa is the 
worst in the world [1]. Hospital inpatients in sub-
Saharan Africa have a high likelihood of having 
HIV, even when admitted for non-infectious 
problems [2-21]. Most inpatients do not know their 
HIV status, unless the hospital has routine 
counseling and HIV testing of inpatients [22]. 
Zambia is one of the countries most greatly affected 
by HIV/AIDS (estimated16.5% of the adult 
population in 2004) [23-25], yet routine inpatient 
testing is rarely available.  
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We conducted a survey of inpatients in 2003, just 
prior to the 2004-2005 rapid expansion of HIV care 
and treatment with antiretroviral therapy (ART) in 
Lusaka, Zambia [26]. We then repeated the survey in 
2006 to assess how community availability of ART 
might have altered HIV-related hospital inpatient 
characteristics.  
METHODS
The University Teaching Hospital (UTH) has 9 
medical wards: one medical admissions ward, 6 
“low cost” wards serving very low income patients, 
and 2 “high cost” wards for which patients pay extra 
fees. Our two cross-sectional surveys were 
conducted on the same medical admissions ward 
(serving all persons without extra fees) during May-
June 2003 and again during May-June 2006. Every 
adult inpatient aged >17 years old admitted to the 
medical admissions ward was eligible unless they 
were so critically ill, intoxicated, or mentally 
impaired that they could not give consent and/or be 
interviewed. Patients chosen for the study were 
randomly selected from the ward roster and 
approached by a nurse-counselor, a physician, or a 
medical student in a private area. After thoroughly 
explaining the study, the practitioner gained verbal 
informed consent from willing inpatients. 
Participants completed a short questionnaire, 
received pre-test counseling, and a 2 mL blood 
sample was drawn.  
In 2003, patients were counseled and tested off the 
ward in the hospital's outpatient voluntary HIV 
counseling and testing (VCT) center. In 2006, the 
counseling and testing was done on or near the ward 
itself. All willing and available patients received 
post-test counseling and HIV test results. Bias from 
the person administrating the questionnaire was 
minimized by having trained counselors who were 
unaware of the patients' HIV status at the time of the 
interview.
For both the 2003 and 2006 surveys, we recruited at 
least 100 willing patients of unknown status to 
determine a 56% +9% prevalence with 95% 
confidence. Dual positivity on two rapid tests was 
TM
diagnostic for HIV infection. We used Determine  
(Abbott Laboratories, Minato-Ku Tokyo, Japan) and 
TM
Genie II HIV-1/HIV-2  (Bio-Rad Laboratories, 
Marne-la-Coquette, France) tests, with further 
TM
testing using a Magnetic Elisa Bionor  test (Bionor 
A/S, Skien, Norway) if the Determine™ and Genie 
II™ assays were discordant.  
The questionnaire assessed patient demographics, 
including age, sex, symptoms, diagnosis, education 
level, fluency in English, and native language. We 
only collected data on those inpatients who had no 
prior knowledge of seropositive status. Data were 
entered into spreadsheets (Excel™, Microsoft Corp, 
Redmond, WA, USA) and analyzed with SAS™ 
version 9.1 (SAS, Inc., Cary, NC, USA) and with 
EpiInfo™ version 3.5.1 (Centers for Diseases 
Control and Prevention, Atlanta, GA, USA). 
Differences in frequencies were assessed with a Chi-
square test using Yates' correction. Ethical approval 
for the study was obtained from the Research Ethics 
Committee at the University of Zambia (both years) 
and the Institutional Review Boards of the 
University of Alabama at Birmingham (2003 
survey) and Vanderbilt University (2006 survey). 
RESULTS 
Table 1. Comparisons between inpatients of 2003 and 
2006 in their acceptance of voluntary counseling and 
testing (VCT), prior knowledge of status, and receipt of 
post-test counseling and HIV test results on the medical 
admission ward of the University Teaching Hospital, 
Lusaka, Zambia
*  p<0.000001 by Chi square test with Yates' correction.
Note: In 2003, patients received their post-test counseling off-
the-ward at the hospital VCT center and fully 45.1% of patients 
were discharged home before they could see the counseling and 
learn their status. In 2006, we provided the counseling and 
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VCT center for test results. In 2006 when VCT was 
made available on or near the ward itself, 99.0% of 
inpatients (99 of 100) received post-test counseling 
and 99.1% (98 of 99) of them learned their status. 
Characteristics of inpatients of unknown HIV status 
were largely similar between the 2003 and 2006 
surveys, though higher seroprevalence among 
persons >40 years old was noted in 2003 compared 
to 2006 (Table 2).  
DISCUSSION
We found inpatient prevalence to be exceedingly 
high in a general medical ward of the University 
Teaching Hospital in Lusaka, Zambia, 62.8% in 
2003 (all with prior unknown status) and 73.1% in 
2006 (or 48% among persons of unknown status). 
Thus, while HIV contributes to the inpatient burden 
in the University Teaching Hospital medical wards 
testing on the ward itself, such that only 1 person (1.0%) was 
discharged home before receiving post-test counseling and test 
results. 
In 2003, no one who was asked to participate in the 
study was aware of being HIV-seropositive and no 
one was on ART. In 2003, 99.0% (102 of 103) of 
inpatients agreed to participate and receive VCT. In 
2006, 49.3% (99 of 201) of inpatients who were 
asked to participate knew they were HIV-
seropositive and all 99 persons were on ART. Of the 
remaining persons of unknown status in 
2006, 98.0% (100 of 102) agreed to 
participate and receive VCT (Table 1).  
In 2003, 62.8% (64 of 102) of status-
unknown inpatients agreeing to testing 
were seropositive by dual rapid test; a 
somewhat higher proportion of women 
was infected than men (67.9% vs. 57.1%, 
respectively; p=0.4). In 2006, 48.0% (48 
of 100) of status-unknown inpatients 
agreeing to testing were seropositive by 
dual rapid test; a slightly higher 
proportion of women was infected than 
men (50% vs. 46.0%, respectively; 
p=0.8). When including inpatients who 
already knew their seropositive status, 
plus those unknowns who tested 
seropositive, the proportion of inpatients 
that was seropositive in 2006 was 73.1% 
(147 of 201). Status-unknown inpatients 
in 2003 were more likely to be HIV-
infected in 2003 than in 2006 (odds ratio 
= 1.8; 95% CI: 1.0-3.3; p=0.05), though 
among all inpatients approached 
(including those who knew their HIV-
seropositive status), the proportion 
infected was lower in 2003 than in 2006, 
although this difference was not 
statistically significant (odds ratio = 0.62; 
95% CI: 0.36-1.1; p=0.08). No one in 
either year had indeterminate HIV status. 
In 2003, only 54.9% (56 of 102) of inpatients 
received post-test counseling and 98.2% (55 of 56) 
agreed to receive their HIV test results (Table 1). By 
the time post-test counseling was provided by the 
hospital VCT center for the 2003 inpatients, 45.1% 
of them had been discharged, none of whom (among 
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Table 2: Characteristics of HIV-seropositive and seronegative 
inpatients with initially unknown serostatus on the medical 
admissions ward of the University Teaching Hospital, Lusaka, 
Zambia, in parallel 2003 and 2006 surveys
*p=0.02 by Chi square with Yates' correction, comparing the 
proportion of persons >40 years of age who were seropositive in 
2003 with 2006.
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more than ever, expanded outpatient care and ART 
were reaching a substantial pool of persons such that 
many more patients already knew their HIV status in 
2006 compared to 2003.  HIV/AIDS services in 
Zambia, largely provided by government clinics and 
supported by the President's Emergency Plan for 
AIDS Relief (PEPFAR; www.pepfar.gov), have 
enabled many Zambians to become aware of their 
status, bridging them to care as needed [26]. That so 
many known HIV-infected persons who are on ART 
nonetheless became in-patients in 2006 suggests just 
how sick many out-patients with HIV are in Zambia, 
as well as on-going challenges in community-based 
out-patient programs.
It was notable that all inpatients who know that they 
were HIV-infected in 2006 were already on ART. It 
may be that persons in HIV outpatient care were 
more likely to get inpatient hospital care when they 
needed it, and/or that persons with higher CD4+ T-
cell counts who are not on ART are unlikely to be 
admitted. Tanzanian hospital data suggest that HIV 
infection is highest among patients with an infective 
condition [5]; this may be why the Ugandan medical 
ward patients had the highest HIV prevalence rates 
[32]. We only surveyed medical ward patients and 
therefore cannot comment on comparisons between 
patients on different hospital wards.
Nearly all inpatients agreed to VCT when it was 
offered, both in 2003 and 2006, unlike the Zambian 
experience in outpatient antenatal care settings that 
has seen lower-than-ideal uptake in VCT [27-30]. In 
Tanzania, HIV testing was agreed to by 67.2% of 
surgical in-patients in a December 2001-February 
2002 survey, but this predated widespread 
availability of ART, an incentive to get tested [31]. 
From November 2004 to February 2006, universal 
and “opt-out” routine screening in a Ugandan 
hospital demonstrated a 98% uptake among 
inpatients and outpatients with the highest HIV 
seroprevalence among medical inpatients [32]. In 
this  study, fewer than half of the seropositive 
inpatients received their test results before they were 
discharged in 2003, but nearly all received their post-
test counseling and their HIV test results in the 2006 
survey. This substantial improvement results, we 
think, from the 2006 strategy to provide VCT on the 
wards rather than relying on the hospital VCT center, 
as was done in 2003. Given that only one patient in 
each of the two years who received post-test 
counseling refused to collect the HIV result, we 
believe that our study, along with the experience 
throughout Africa [2, 4-22, 31-33], suggests the 
hospital to be a superb venue for routine HIV testing 
and counseling. 
Studies done in Zambia on the implementation of 
same-day VCT in antenatal clinics have shown 
reasonably high uptake among outpatients as well 
[27-30]. VCT for pregnant women in Lusaka 
includes same-day rapid tests and on-site post-test 
counseling as an entry point for provision of family-
centered ART [28]. We do not think it is surprising 
that sick inpatients were even more willing to be 
tested than were women in antenatal care, given that 
benefits of diagnosis (i.e., use of ART) for the sick 
patient are more intuitive than for the asymptomatic 
pregnant woman for prevention of transmission of 
HIV to the fetus.
The first documented hospital-based HIV 
prevalence survey in Zambia was done in 1985, also 
at UTH . Even in the early and mid-1980s, HIV rates 
were rising steeply in Zambia [24,25]. In men, the 
seroprevalence was highest (32.9%) in 30-35 year 
olds and in women it peaked (24.4%) in 20-25 year 
olds [3]. Seropositivity rates were higher in patients 
with an infectious problem (23.4%) than in those 
without (11.4%) [3]. These early data suggest that it 
would have been desirable to institute inpatient 
screening for HIV at UTH >20 years ago. 
ART was limited in 2003 to those who could pay. 
ART was initiated in selected clinics under a 
Government of Zambia initiative during late 2003, 
and was expanded markedly in 2004-2005 to all 
Lusaka clinics with PEPFAR support. As of 
November 5, 2005, just 6 months before our 2006 
survey, 21,755 adults had been enrolled into HIV 
care and 16,198 (75%) of them had started ART 
within the PEPFAR program, the dominant 
contributor to HIV care in Lusaka at that time [26]. 
Our data suggest success in widely expanding HIV 
testing in out-patient venues, but also may suggest 
that treatment failure (as measured by an HIV-
infected person on ART being hospitalized) is 
prevalent.
Our sample is not likely to be biased since we 
selected randomly from general medical ward 
admissions from a ward of mixed social class. There 
were no evident shifts in admissions criteria from 
2003 to 2006 (NGK, ISZ, and DC, personal 
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observations). A limitation of our study is that we 
cannot generalize to the rest of the hospital (e.g., 
surgery, obstetrics and gynecology, and pediatrics) 
as we did not survey those wards. While Western blot 
confirmation was unaffordable in our setting, we 
believe that misclassification is unlikely with our 
dual rapid test [34]. 
Our experience suggests strongly that HIV testing is 
feasible and well-accepted in a large Zambian 
hospital. Ward-based counseling and testing is 
superior to sending patients for VCT off the ward 
since both rapid testing and post-test counseling can 
occur before the patient is discharged from hospital. 
Based, in part, on the results of these two surveys, the 
U.S. Centers for Disease Control and Prevention 
Zambia office began fiscal support in 2007 of a 
ward-based, routine counseling and testing service 
in the UTH medical admissions ward as part of the 
PEPFAR initiative with the Zambian Ministry of 
Health. Just in the first two months of operation in 
2007, >600 patients were tested with subsequent 
expansion of the service hospital-wide. The program 
has been sustained and expanded through the present 
(September 2010). Hospital HIV testing services can 
serve as valuable surveillance sites to assess the 
impact of expanded outpatient HIV services. The 
Lusaka-wide expansion of care and ART has led to a 
huge increase in the number of inpatients who knew 
they were HIV-infected, but had not yet resulted in a 
decline in the proportion of inpatients who were 
HIV-infected. Hospital-based HIV testing services 
are of vital clinical and public health importance [35-
39]. These data are a tool for epidemiologic and 
operations research to help set priorities for HIV-
related investments and to help evaluate the 
community impact of outpatient AIDS services [40, 
41].
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